After repeatedly wowing investors, Roche’s star eye med Vabysmo collected more than $4 billion in sales during its third year on the market. | After repeatedly wowing investors, Roche’s star eye med ...

The syringe filling machine industry is experiencing significant growth due to the increasing demand for injectable medications, particularly with the rise of biologics, vaccines, and precision ...

AUSTIN, TX, UNITED STATES, January 20, 2025 /EINPresswire / -- According to Research by SNS Insider, The Oral Syringes market ... The need for exact drug administration, notably in hospitals ...

This creates a significant demand for oral syringes, which ensure accurate and controlled administration, especially in regions with high COPD prevalence. The rising number of surgical procedures ...

This creates a significant demand for oral syringes, which ensure accurate and controlled administration, especially in regions with high COPD prevalence. The rising number of surgical procedures in ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

The Food and Drug Administration (FDA or we) is amending the color additive regulations to provide for the safe use of myoglobin as a color additive in ground meat and ground poultry analogue products ...

VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is tapping contracting juggernaut Thermo Fisher Scientific to help meet its ...

Esomeprazole magnesium oral capsule is a generic prescription drug that’s used to treat conditions caused by excess stomach acid production. Its delayed-release formulation releases the drug ...

More than 65% of the participants indicated that they would be willing to purchase a reusable oral dosing syringe for administering liquid drugs in their homes.

The Biden administration in November proposed allowing Medicare and Medicaid to cover obesity medications such as Novo Nordisk’s Wegovy and Zepbound from Eli Lilly. The drugs have been shown to ...